Harnessing monocyte-derived dendritic cells for evaluating T cell response by mixed leukocyte reaction

Abstract

The mixed leukocyte reaction (MLR) is a pivotal in vitro assay for evaluating T-cell responses stimulated by allogeneic antigen-presenting cells (APCs). Dendritic cells (DCs) are the most efficient stimulatory cells. However, the scarcity of circulating DCs in peripheral blood limits their isolation for research or clinical use. In contrast, monocytes, which are abundant and easily accessible, can be differentiated into monocyte-derived DCs (moDCs) in vitro and have emerged as the most practical and efficient stimulatory cells for MLR due to their accessibility and robust allostimulatory capabilities. This review aims to describe the scientific rationale and evidence for using moDCs in MLR assays to assess T-cell alloreactivity. Its methodology outlines the protocols for experimental, preclinical, and biosafety assays that have demonstrated the practicality of moDCs in evaluating and quantifying the alloresponse of naïve and memory CD4⁺ and CD8⁺ T cells, as well as the effects of immunomodulatory factors, immune monitoring, and tolerogenic strategies in the context of transplantation. Additionally, it illustrates how moDC-mediated MLRs have provided critical insights into understanding alloimmunity processes and antigen-specific T-cell responses in cancer immunotherapy, autoimmune diseases, and vaccine development, with potential implications for personalized medicine and immunotherapy optimization. In conclusion, despite ongoing challenges such as standardization and scalability in massive cell production, the current understanding and reproducible results of moDC applications in MLRs highlight their potential to develop innovative strategies focused on immune monitoring.

Keywords

Monocyte-derived dendritic cells / mixed leukocyte reaction / alloreactivity / antigen-specific responses / cancer / autoimmunity / vaccines / immunotherapy

References

[1] Bosma DMT, Busselaar J, Staal MD, Frijlink E, Mack M, Salerno F, et al. CD4⁺ T-cell help delivery to monocyte-derived dendritic cells promotes effector differentiation of helper and cytotoxic T cells . Immunol Lett. 2025; 275: 107022.

[2] Fayette J, Durand I, Bridon JM, Arpin C, Dubois B, Caux C, et al. Dendritic cells enhance the differentiation of naïve B cells into plasma cells in vitro. Scand J Immunol. 1998; 48: 563-70.

[3] Villani A, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017; 356: eaah4573.

[4] Orsini G, Legitimo A, Failli A, Massei F, Biver P, Consolini R. Enumeration of human peripheral blood dendritic cells throughout the life. Int Immunol. 2012; 24: 347-56.

[5] Coillard A, Segura E. In vivo Differentiation of Human Monocytes . Front Immunol. 2019; 10: 1907.

[6] Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 1994; 179: 1109-18.

[7] Plumas J. Harnessing dendritic cells for innovative therapeutic cancer vaccines. Curr Opin Oncol. 2022; 34: 161-8.

[8] Ochando J, Ordikhani F, Jordan S, Boros P, Thomson AW. Tolerogenic dendritic cells in organ transplantation. Transpl Int. 2020; 33: 113-27.

[9] Mangelinck A, Dubuisson A, Becht E, Dromaint-Catesson S, Fasquel M, Provost N, et al. Characterization of CD4⁺ and CD8⁺ T cells responses in the mixed lymphocyte reaction by flow cytometry and single cell RNA sequencing . Front Immunol. 2024; 14: 1320481.

[10] Barra G, Gallo C, Carbone D, Ziaco M, Dell’Isola M, Affuso M, et al. The immunoregulatory effect of the TREM2-agonist Sulfavant A in human allogeneic mixed lymphocyte reaction. Front Immunol. 2023; 14: 1050113.

[11] Macedo C, Tran LM, Zahorchak AF, Dai H, Gu X, Ravichandran R, et al. Donor-derived regulatory dendritic cell infusion results in host cell cross-dressing and T cell subset changes in prospective living donor liver transplant recipients. Am J Transplant. 2021; 21: 2372-86.

[12] Chen X, Hao S, Zhao Z, Liu J, Shao Q, Wang F, et al. Interleukin 35: Inhibitory regulator in monocyte-derived dendritic cell maturation and activation. Cytokine. 2018; 108: 43-52.

[13] Torres-Aguilar H, Aguilar-Ruiz SR, González-Pérez G, Munguía R, Bajaña S, Meraz-Ríos MA, et al. Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells. J Immunol. 2010; 184: 1765-75.

[14] Godfrey WR, Krampf MR, Taylor PA, Blazar BR. Ex vivo depletion of alloreactive cells based on CFSE dye dilution, activation antigen selection, and dendritic cell stimulation. Blood. 2004; 103: 1158-65.

[15] Lee JJ, Kook H, Park MS, Nam JH, Choi BH, Song WH, et al. Immunotherapy using autologous monocyte-derived dendritic cells pulsed with leukemic cell lysates for acute myeloid leukemia relapse after autologous peripheral blood stem cell transplantation. J Clin Apher. 2004; 19: 66-70.

[16] Scheinecker C, Machold KP, Majdic O, Höcker P, Knapp W, Smolen JS. Initiation of the autologous mixed lymphocyte reaction requires the expression of costimulatory molecules B7-1 and B7-2 on human peripheral blood dendritic cells. J Immunol. 1998; 161: 3966-73.

[17] Bingaman AW, Farber DL. Memory T cells in transplantation: generation, function, and potential role in rejection. Am J Transplant. 2004; 4: 846-52.

[18] Zhuang Q, Liu Q, Divito SJ, Zeng Q, Yatim KM, Hughes AD, et al. Graft-infiltrating host dendritic cells play a key role in organ transplant rejection. Nat Commun. 2016; 7: 12623.

[19] Zoghi S, Masoumi F, Rezaei N. The immune system. In: Clinical Immunology. Elsevier; 2023. pp. 1-46.

[20] Quah BJC, O’Neill HC. Maturation of function in dendritic cells for tolerance and immunity. J Cell Mol Med. 2005; 9: 643-54.

[21] Tiberio L, Prete AD, Schioppa T, Sozio F, Bosisio D, Sozzani S. Chemokine and chemotactic signals in dendritic cell migration. Cell Mol Immunol. 2018; 15: 346-52.

[22] Carenza C, Calcaterra F, Oriolo F, Vito CD, Ubezio M, Porta MGD, et al. Costimulatory Molecules and Immune Checkpoints Are Differentially Expressed on Different Subsets of Dendritic Cells. Front Immunol. 2019; 10: 1325.

[23] Torres-Aguilar H, Blank M, Jara LJ, Shoenfeld Y. Tolerogenic dendritic cells in autoimmune diseases: crucial players in induction and prevention of autoimmunity. Autoimmun Rev. 2010; 10: 8-17.

[24] Leblanc-Hotte A, Audiger C, Chabot-Roy G, Lombard-Vadnais F, Delisle J, Peter Y, et al. Immature and mature bone marrow-derived dendritic cells exhibit distinct intracellular mechanical properties. Sci Rep. 2023; 13: 1967.

[25] Bourque J, Hawiger D. Variegated Outcomes of T Cell Activation by Dendritic Cells in the Steady State. J Immunol. 2022; 208: 539-47.

[26] Stebegg M, Bignon A, Hill DL, Silva-Cayetano A, Krueger C, Vanderleyden I, et al. Rejuvenating conventional dendritic cells and T follicular helper cell formation after vaccination. Elife. 2020; 9: e52473.

[27] Segura E, Valladeau-Guilemond J, Donnadieu M, Sastre-Garau X, Soumelis V, Amigorena S. Characterization of resident and migratory dendritic cells in human lymph nodes. J Exp Med. 2012; 209: 653-60.

[28] Abboud G, Elshikha AS, Kanda N, Zeumer-Spataro L, Morel L. Contribution of Dendritic Cell Subsets to T Cell-Dependent Responses in Mice. J Immunol. 2022; 208: 1066-75.

[29] Dutertre C. A new step in understanding mouse cDC ontogeny. Nat Immunol. 2024; 25: 383-4.

[30] Villar J, Segura E. Decoding the Heterogeneity of Human Dendritic Cell Subsets. Trends Immunol. 2020; 41: 1062-71.

[31] Ożańska A, Szymczak D, Rybka J. Pattern of human monocyte subpopulations in health and disease. Scand J Immunol. 2020; 92: e12883.

[32] Ginhoux F, Jung S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat Rev Immunol. 2014; 14: 392-404.

[33] Capucha T, Mizraji G, Segev H, Blecher-Gonen R, Winter D, Khalaileh A, et al. Distinct Murine Mucosal Langerhans Cell Subsets Develop from Pre-dendritic Cells and Monocytes. Immunity. 2015; 43: 369-81.

[34] Hambleton S, Salem S, Bustamante J, Bigley V, Boisson-Dupuis S, Azevedo J, et al. IRF8 mutations and human dendritic-cell immunodeficiency. N Engl J Med. 2011; 365: 127-38.

[35] Mehta H, Angsana J, Bissonnette R, Muñoz-Elías EJ, Sarfati M. Inflammatory Skin Disorders: Monocyte-Derived Cells Take Center Stage. Front Immunol. 2021; 12: 691806.

[36] Tang-Huau T, Segura E. Human in vivo-differentiated monocyte-derived dendritic cells. Semin Cell Dev Biol. 2019; 86: 44-9.

[37] Dzionek A, Fuchs A, Schmidt P, Cremer S, Zysk M, Miltenyi S, et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol. 2000; 165: 6037-46.

[38] Nair S, Archer GE, Tedder TF. Isolation and generation of human dendritic cells. Curr Protoc Immunol. 2012; 99: 7.32.1-23.

[39] Wall DM, Thompson M, Mileshkin L, Loveland B, Coverdale J, Xing PX, et al. Tracking Dendritic Cells In Vivo in Patients with Multiple Myeloma. Blood. 2005; 106: 3469.

[40] Zhuang Q, Cai H, Cao Q, Li Z, Liu S, Ming Y. Tolerogenic Dendritic Cells: The Pearl of Immunotherapy in Organ Transplantation. Front Immunol. 2020; 11: 552988.

[41] Cechim G, Chies JAB. In vitro generation of human monocyte-derived dendritic cells methodological aspects in a comprehensive review . An Acad Bras Cienc. 2019; 91.

[42] Armitage LH, Khosravi-Maharlooei M, Meacham A, Butfiloski EJ, Viola R, Egli D, et al. High-Yield Monocyte, Macrophage, and Dendritic Cell Differentiation from Induced Pluripotent Stem Cells. bioRxiv 2021.04.29.441947 [Preprint]. 2021 [cited 2024 April 8]. Available from: https://www.biorxiv.org/content/10.1101/2021.04.29.441947v1

[43] Cunningham S, Hackstein H. Rapid generation of monocyte-derived antigen-presenting cells with dendritic cell-like properties. Transfusion. 2021; 61: 1845-55.

[44] Gardner A, de Mingo Pulido Á, Ruffell B. Dendritic Cells and Their Role in Immunotherapy. Front Immunol. 2020; 11: 924.

[45] Cheever MA, Higano CS. PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine. Clin Cancer Res. 2011; 17: 3520-6.

[46] Döring M, Blees H, Koller N, Tischer-Zimmermann S, Müsken M, Henrich F, et al. Modulation of TAP-dependent antigen compartmentalization during human monocyte-to-DC differentiation. Blood Adv. 2019; 3: 839-50.

[47] Fisher JD, Zhang W, Balmert SC, Aral AM, Acharya AP, Kulahci Y, et al. In situ recruitment of regulatory T cells promotes donor-specific tolerance in vascularized composite allotransplantation. Sci Adv. 2020; 6: eaax8429.

[48] Iwahara N, Hotta K, Iwami D, Tanabe T, Tanaka Y, Ito YM, et al. Analysis of T-cell alloantigen response via a direct pathway in kidney transplant recipients with donor-specific antibodies . Front Immunol. 2023; 14: 1164794.

[49] Siu JHY, Surendrakumar V, Richards JA, Pettigrew GJ. T cell Allorecognition Pathways in Solid Organ Transplantation. Front Immunol. 2018; 9: 2548.

[50] Smyth LA, Lechler RI, Lombardi G. Continuous Acquisition of MHC:Peptide Complexes by Recipient Cells Contributes to the Generation of Anti-Graft CD8⁺ T Cell Immunity . Am J Transplant. 2017; 17: 60-8.

[51] Hu C, Wu Z, Li L. Mesenchymal stromal cells promote liver regeneration through regulation of immune cells. Int J Biol Sci. 2020; 16: 893-903.

[52] Pilat N, Lefsihane K, Brouard S, Kotsch K, Falk C, Steiner R, et al. T- and B-cell therapy in solid organ transplantation: current evidence and future expectations. Transpl Int. 2021; 34: 1594-606.

[53] Louis K, Macedo C, Bailly E, Lau L, Ramaswami B, Marrari M, et al. Coordinated Circulating T Follicular Helper and Activated B Cell Responses Underlie the Onset of Antibody-Mediated Rejection in Kidney Transplantation. J Am Soc Nephrol. 2020; 31: 2457-74.

[54] Kern B, Martin F, Mengwasser J, Reutzel-Selke A, Ashraf MI, Fuehrer K, et al. 427.1: Donor Dendritic Cell Depletion Allows Novel Insights Into the Alloimmune Response Following Murine Composite Tissue and Skin Transplantation. Transplantation. 2022; 106: S493-4.

[55] Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol. 2007; 7: 610-21.

[56] Tanriver Y, Ratnasothy K, Bucy RP, Lombardi G, Lechler R. Targeting MHC class I monomers to dendritic cells inhibits the indirect pathway of allorecognition and the production of IgG alloantibodies leading to long-term allograft survival. J Immunol. 2010; 184: 1757-64.

[57] Morelli AE, Larregina AT. Concise Review: Mechanisms Behind Apoptotic Cell-Based Therapies Against Transplant Rejection and Graft versus Host Disease. Stem Cells. 2016; 34: 1142-50.

[58] Moreau A, Kervella D, Bouchet-Delbos L, Braudeau C, Saïagh S, Guérif P, et al. A Phase I/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipients. Kidney Int. 2023; 103: 627-37.

[59] Torres-Aguilar H, Sánchez-Torres C, Jara LJ, Blank M, Shoenfeld Y. IL-10/TGF-beta-treated dendritic cells, pulsed with insulin, specifically reduce the response to insulin of CD4+ effector/memory T cells from type 1 diabetic individuals. J Clin Immunol. 2010; 30: 659-68.

[60] Stax AM, Gelderman KA, Schlagwein N, Essers MC, Kamerling SWA, Woltman AM, et al. Induction of donor-specific T-cell hyporesponsiveness using dexamethasone-treated dendritic cells in two fully mismatched rat kidney transplantation models. Transplantation. 2008; 86: 1275-82.

[61] Flamann C, Peter K, Kreutz M, Bruns H. Regulation of the Immune Balance During Allogeneic Hematopoietic Stem Cell Transplantation by Vitamin D. Front Immunol. 2019; 10: 2586.

[62] Comi M, Amodio G, Passeri L, Fortunato M, Sio FRSd, Andolfi G, et al. Generation of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene Transfer. Front Immunol. 2020; 11: 1260.

[63] Zhang M, Zheng Y, Sun Y, Li S, Chen L, Jin X, et al. Knockdown of NEAT1 induces tolerogenic phenotype in dendritic cells by inhibiting activation of NLRP3 inflammasome. Theranostics. 2019; 9: 3425-42.

[64] Wu J, Zhang H, Zheng Y, Jin X, Liu M, Li S, et al. The Long Noncoding RNA MALAT1 Induces Tolerogenic Dendritic Cells and Regulatory T Cells via miR155/Dendritic Cell-Specific Intercellular Adhesion Molecule-3 Grabbing Nonintegrin/IL10 Axis . Front Immunol. 2018; 9: 1847.

[65] Zahorchak AF, DeRiggi ML, Muzzio JL, Sutherland V, Humar A, Lakkis FG, et al. Manufacturing and validation of Good Manufacturing Practice-compliant regulatory dendritic cells for infusion into organ transplant recipients. Cytotherapy. 2023; 25: 432-41.

[66] Hopewell EL, Cox C. Manufacturing Dendritic Cells for Immunotherapy: Monocyte Enrichment. Mol Ther Methods Clin Dev. 2020; 16: 155-60.

[67] Li JSY, Robertson H, Trinh K, Raghubar AM, Nguyen Q, Matigian N, et al. Tolerogenic dendritic cells protect against acute kidney injury. Kidney Int. 2023; 104: 492-507.

[68] Ezzelarab MB, Lu L, Shufesky WF, Morelli AE, Thomson AW. Donor-Derived Regulatory Dendritic Cell Infusion Maintains Donor-Reactive CD4⁺CTLA4^hi T Cells in Non-Human Primate Renal Allograft Recipients Treated with CD28 Co-Stimulation Blockade . Front Immunol. 2018; 9: 250.

[69] Costa D, Picascia A, Grimaldi V, Amarelli C, Petraio A, Levi A, et al. Role of HLA matching and donor specific antibody development in long-term survival, acute rejection and cardiac allograft vasculopathy. Transpl Immunol. 2024; 83: 102011.

[70] Zhang Q, Chen Y, Fairchild RL, Heeger PS, Valujskikh A. Lymphoid sequestration of alloreactive memory CD4 T cells promotes cardiac allograft survival. J Immunol. 2006; 176: 770-7.

[71] Suchin EJ, Langmuir PB, Palmer E, Sayegh MH, Wells AD, Turka LA. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J Immunol. 2001; 166: 973-81.

[72] Nonoyama S, Hotta K, Iwahara N, Tanabe T, Hirose T, Harada S, et al. Use of Mixed Lymphocyte Reaction Assay to Evaluate Immune Tolerance before Kidney Transplantation with an Immunosuppression-Free Protocol following Hematopoietic Stem Cell Transplantation from the Same Donor. Nephron. 2023; 147: 621-6.

[73] Fu J, Khosravi-Maharlooei M, Sykes M. High Throughput Human T Cell Receptor Sequencing: A New Window Into Repertoire Establishment and Alloreactivity. Front Immunol. 2021; 12: 777756.

[74] DeWolf S, Shen Y, Sykes M. A New Window into the Human Alloresponse. Transplantation. 2016; 100: 1639-49.

[75] Liu E, Tu W, Law HK, Lau YL. Decreased yield, phenotypic expression and function of immature monocyte-derived dendritic cells in cord blood. Br J Haematol. 2001; 113: 240-6.

[76] Eljaafari A, Farre A, Duperrier K, Even J, Vie H, Michallet M, et al. Generation of helper and cytotoxic CD4+T cell clones specific for the minor histocompatibility antigen H-Y, after in vitro priming of human T cells by HLA-identical monocyte-derived dendritic cells. Transplantation. 2001; 71: 1449-55.

[77] Dillon SR, Lewis KE, Swanson R, Evans LS, Kornacker MG, Levin SD, et al. A Dual ICOS/CD28 Antagonist ICOSL Variant Ig Domain (vIgD) Potently Suppresses Human Mixed Lymphocyte Reactions and Human/NSG Mouse Xenograft Graft vs. Host Disease (GvHD). Biol Blood Marrow Transplant. 2018; 24: S187-8.

[78] Eljaafari-Corbin A, Mazet S, Betuel H, Rigal D, Gebuhrer L. Detection of minor histocompatibility antigen disparities by monocyte-derived dendritic cells in HLA-identical siblings. Immunol Lett. 1997; 56: 462-3.

[79] Kwon M, Choi YJ, Sa M, Park S, Shin E. Two-Round Mixed Lymphocyte Reaction for Evaluation of the Functional Activities of Anti-PD-1 and Immunomodulators. Immune Netw. 2018; 18: e45.

[80] Sharp TA, Gress RE, Sachs DH, Rosenberg SA. Assessment of mixed lymphocyte reactivity in human bone marrow cell cultures. Transplantation. 1985; 40: 551-6.

[81] Shimizu I, Fudaba Y, Shimizu A, Yang Y, Sykes M. Comparison of human T cell repertoire generated in xenogeneic porcine and human thymus grafts. Transplantation. 2008; 86: 601-10.

[82] Li L, Chen X, Zhang Y, Li Q, Qi C, Fei X, et al. Toll-like receptor 2 deficiency promotes the generation of alloreactive Th17 cells after cardiac transplantation in mice. Cell Immunol. 2019; 338: 9-20.

[83] Lindemann M. Ex vivo assessment of cellular immune function - applications in patient care and clinical studies. Tissue Antigens. 2014; 84: 439-49.

[84] Sato T, Deiwick A, Raddatz G, Koyama K, Schlitt HJ. Interactions of allogeneic human mononuclear cells in the two-way mixed leucocyte culture (MLC): influence of cell numbers, subpopulations and cyclosporin. Clin Exp Immunol. 1999; 115: 301-8.

[85] Pissas G, Eleftheriadis T. Assessment of Humoral Alloimmunity in Mixed Lymphocyte Reaction. Bio Protoc. 2019; 9: e3139.

[86] Little CJ, Kim SC, Fechner JH, Post J, Coonen J, Chlebeck P, et al. Early allogeneic immune modulation after establishment of donor hematopoietic cell-induced mixed chimerism in a nonhuman primate kidney transplant model. Front Immunol. 2024; 15: 1343616.

[87] Schwarzbich MA, Gutknecht M, Guettler L, Kanz L, Salih HR, Gruenebach F, et al. Immunosuppressive Drugs Upregulate the Immunoinhibitory Receptor Osteoactivin in Monocyte-Derived Dendritic Cells. Blood. 2011; 118: 3232.

[88] Haidinger M, Poglitsch M, Geyeregger R, Kasturi S, Zeyda M, Zlabinger GJ, et al. A versatile role of mammalian target of rapamycin in human dendritic cell function and differentiation. J Immunol. 2010; 185: 3919-31.

[89] Bedrosian I, Roros JG, Xu S, Nguyen HQ, Engels F, Faries MB, et al. Granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-12 synergize with calcium ionophore to enhance dendritic cell function. J Immunother. 2000; 23: 311-20.

[90] Säemann MD, Kelemen P, Böhmig GA, Hörl WH, Zlabinger GJ. Hyporesponsiveness in alloreactive T-cells by NF-kappaB inhibitor-treated dendritic cells: resistance to calcineurin inhibition. Am J Transplant. 2004; 4: 1448-58.

[91] Min J, Liu L, Wang J, Shang CZ, Wan YL, Yu Q, et al. Morphology and immunological function of immature dendritic cells induced by sodium butyrate in human monocytes. J Clin Rehabil Tissue Eng Res. 2007; 11: 7485-8.

[92] Hoeck JV, Vanhove C, Smedt SCD, Raemdonck K. Non-invasive cell-tracking methods for adoptive T cell therapies. Drug Discov Today. 2022; 27: 793-807.

[93] Protheroe RE, Steward CG, Mazza G, Wraith DC. Human CD4⁺CD25⁺CD127⁻ T Cells Show Potent Dose-Dependent Inhibition of Allogeneic DC-Driven MLRs . Blood. 2006; 108: 5172.

[94] Hlavackova E, Pilatova K, Cerna D, Selingerova I, Mudry P, Mazanek P, et al. Dendritic Cell-Based Immunotherapy in Advanced Sarcoma and Neuroblastoma Pediatric Patients: Anti-cancer Treatment Preceding Monocyte Harvest Impairs the Immunostimulatory and Antigen-Presenting Behavior of DCs and Manufacturing Process Outcome. Front Oncol. 2019; 9: 1034.

[95] Bellone G, Carbone A, Smirne C, Scirelli T, Buffolino A, Novarino A, et al. Cooperative induction of a tolerogenic dendritic cell phenotype by cytokines secreted by pancreatic carcinoma cells. J Immunol. 2006; 177: 3448-60.

[96] Hlavackova E, Pilatova K, Fedorova L, Mudry P, Mazanek P, Sterba J, et al. Pharmacotherapy preceding monocyte harvest interferes with the potency of monocyte-derived dendritic cell anticancer vaccine. Ann Oncol. 2019; 30: xi13.

[97] Almeida CVD, Zamame JA, Romagnoli GG, Rodrigues CP, Magalhães MB, Amedei A, et al. Treatment of colon cancer cells with 5-fluorouracil can improve the effectiveness of RNA-transfected antitumor dendritic cell vaccine. Oncol Rep. 2017; 38: 561-8.

[98] Neves AR, Ensina LFC, Anselmo LB, Leite KRM, Buzaid AC, Câmara-Lopes LH, et al. Dendritic cells derived from metastatic cancer patients vaccinated with allogeneic dendritic cell-autologous tumor cell hybrids express more CD86 and induce higher levels of interferon-gamma in mixed lymphocyte reactions. Cancer Immunol Immunother. 2005; 54: 61-6.

[99] Radice E, Bellone G, Miranda V. Enhancement of the Immunostimulatory Functions of Ex Vivo-Generated Dendritic Cells from Early-Stage Colon Cancer Patients by Consecutive Exposure to Low Doses of Sequential-Kinetic-Activated IL-4 and IL-12. A Preliminary Study. Transl Oncol. 2015; 8: 327-38.

[100] Trepiakas R, Pedersen AE, Met O, Hansen MH, Berntsen A, Svane IM. Comparison of alpha-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients. Vaccine. 2008; 26: 2824-32.

[101] Fang KK, Lee JB, Zhang L. Adoptive Cell Therapy for T-Cell Malignancies. Cancers (Basel). 2022; 15: 94.

[102] Mo F, Srinivasan M, Heslop HE, Brenner MK, Mamonkin M. Rejection-Resistant Off-the-Shelf T Cells for Adoptive Cell Therapy. Biol Blood Marrow Transplant. 2019; 25: S168.

[103] Ganguly D, Chamilos G, Lande R, Gregorio J, Meller S, Facchinetti V, et al. Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J Exp Med. 2009; 206: 1983-94.

[104] Torres-Aguilar H, Blank M, Kivity S, Misgav M, Luboshitz J, Pierangeli SS, et al. Tolerogenic dendritic cells inhibit antiphospholipid syndrome derived effector/memory CD4⁺ T cell response to β2GPI. Ann Rheum Dis. 2012; 71: 120-8.

[105] Ju X, Silveira PA, Hsu W, Elgundi Z, Alingcastre R, Verma ND, et al. The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population. J Immunol. 2016; 197: 4613-25.

[106] Vaknin-Dembinsky A, Balashov K, Weiner HL. IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production. J Immunol. 2006; 176: 7768-74.

[107] Tai Y, Wang Q, Korner H, Zhang L, Wei W. Molecular Mechanisms of T Cells Activation by Dendritic Cells in Autoimmune Diseases. Front Pharmacol. 2018; 9: 642.

[108] Andreakos E, Smith C, Monaco C, Brennan FM, Foxwell BM, Feldmann M. IκB kinase 2 but not NF-κB-inducing kinase is essential for effective DC antigen presentation in the allogeneic mixed lymphocyte reaction. Blood. 2003; 101: 983-91.

[109] Volchenkov R, Brun JG, Jonsson R, Appel S. In vitro suppression of immune responses using monocyte-derived tolerogenic dendritic cells from patients with primary Sjögren’s syndrome. Arthritis Res Ther. 2013; 15: R114.

[110] Ríos-Ríos WdJ, Sosa-Luis SA, Torres-Aguilar H. Current advances in using tolerogenic dendritic cells as a therapeutic alternative in the treatment of type 1 diabetes. World J Diabetes. 2021; 12: 603-15.

[111] Qu C, Brinck-Jensen N, Zang M, Chen K. Monocyte-derived dendritic cells: targets as potent antigen-presenting cells for the design of vaccines against infectious diseases. Int J Infect Dis. 2014; 19: 1-5.

[112] Liaqat F, Kangethe RT, Pichler R, Liu B, Huber J, Wijewardana V, et al. Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells. J Vis Exp. 2023; 195: e64874.

[113] Ersland K, Wüthrich M, Klein BS. Dynamic interplay among monocyte-derived, dermal, and resident lymph node dendritic cells during the generation of vaccine immunity to fungi. Cell Host Microbe. 2010; 7: 474-87.

[114] Jonny J, Putranto TA, Yana ML, Sitepu EC, Irfon R, Ramadhani BP, et al. Safety and efficacy of dendritic cell vaccine for COVID-19 prevention after 1-Year follow-up: phase I and II clinical trial final result. Front Immunol. 2023; 14: 1122389.

[115] Patente TA, Pinho MP, Oliveira AA, Evangelista GCM, Bergami-Santos PC, Barbuto JAM. Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy. Front Immunol. 2019; 9: 3176.

[116] Milhau N, Almouazen E, Bouteille S, Hellel-Bourtal I, Azzouz-Maache S, Benavides U, et al. In vitro evaluations on canine monocyte-derived dendritic cells of a nanoparticles delivery system for vaccine antigen against Echinococcus granulosus. PLoS One. 2020; 15: e0229121.

[117] Hu Y, Su X, Liu L, Xiang Y, Yu Q, Yi S, et al. [Isolation, amplification and identification of human natural CD4⁺CD25⁺ regulatory T cells in vitro]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2014; 39: 818-24.

[118] Xie L, Liu G, Liu Y, Yu Y. In vitro and In vivo CD8⁺ T Cell Suppression Assays . Bio Protoc. 2021; 11: e4020.

[119] Zahorchak AF, Kean LS, Tokita D, Turnquist HR, Abe M, Finke J, et al. Infusion of stably immature monocyte-derived dendritic cells plus CTLA4Ig modulates alloimmune reactivity in rhesus macaques. Transplantation. 2007; 84: 196-206.